Related Experiment Video
Updated: May 22, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning
Matthew M Churpek1,2, Kyle A Carey3, Ashley Snyder4
1Department of Medicine, University of Wisconsin-Madison, Madison, WI.
A new machine learning model, eCARTv5, significantly improves early detection of clinical deterioration in hospitalized patients compared to existing scores. This advanced early warning system shows promise for better patient outcomes and has received FDA clearance.
Area of Science:
- Medical Informatics
- Clinical Decision Support Systems
- Machine Learning in Healthcare
Background:
- Early detection of clinical deterioration is crucial for improving patient outcomes.
- Existing machine learning early warning scores often lack rigorous validation and subgroup analysis.
- Traditional logistic regression models have limitations in capturing complex patient data.
Purpose of the Study:
- To develop and prospectively validate a gradient-boosted machine model, eCARTv5, for identifying clinical deterioration in hospitalized patients.
- To compare the performance of eCARTv5 against established early warning scores like MEWS and NEWS.
- To ensure the model's robustness across diverse patient populations and clinical scenarios.
Main Methods:
- Utilized a gradient-boosted trees algorithm with predictor variables including demographics, vital signs, documentation, and laboratory values.
- Developed the model (eCARTv5) using a large dataset from adult patients in inpatient medical-surgical wards (2006-2022).
- Externally validated the model retrospectively (2009-2023) and prospectively (2023-2024) across multiple health systems.
Main Results:
- eCARTv5 demonstrated superior performance with the highest Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.834 in retrospective validation.
- Outperformed eCARTv2 (0.775), NEWS (0.766), and MEWS (0.704) in retrospective validation.
- Maintained high performance (AUROC ≥0.80) across various patient demographics, clinical conditions, and in prospective validation.
Conclusions:
- The developed eCARTv5 model offers improved accuracy in identifying clinical deterioration compared to existing scores.
- eCARTv5's validated performance across diverse subgroups and prospective testing supports its clinical utility.
- The study's findings provided the basis for FDA clearance, enabling eCARTv5's use in clinical settings for hospitalized ward patients.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018